Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responsesGiulia Fulci, E. Antonio Chiocca, Davide Gianni et al.|Proceedings of the National Academy of Sciences|2006Cited by 360
oHSV-P10 reduces glioma stem cell enrichment after oncolytic HSV therapyUpasana Sahu, Balveen Kaur|Molecular Therapy — Oncolytics|2023Cited by 12
IDH status dictates oHSV mediated metabolic reprogramming affecting anti-tumor immunityUpasana Sahu, Balveen Kaur|Nature Communications|2025Cited by 11